Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-08-07

FDA Approved: MITOSOL — Supplemental Application (Mobius Therapeutics LLC)

View source ↗

Summary

FDA approved a supplemental application for MITOSOL (mitomycin C) from Mobius Therapeutics LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MITOSOL (Mitomycin)

Snippet

SUPPL AP for MITOSOL (MITOMYCIN)